Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07214168 · ClinicalTrials.gov registry record

Vape Use Among Younger & Older Smokers

A clinical trial of Smoking Behaviors and Smoking, Cigarette, sponsored by Abramson Cancer Center at Penn Medicine.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT07214168 is a study of Smoking Behaviors and Smoking, Cigarette that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 100 participants, below the 434-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07214168, a study of Smoking Behaviors and Smoking, Cigarette, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The study aims to recruit 100 current cigarette smokers (50 young adults ages 21-34; 50 older adults ages 35-65) who have tried vaping or are currently vaping (dual users). The study will examine the trajectories in tobacco use (cigarettes and/or ENDS), including the nuanced differences in ENDS use (i.e., detailed device characteristics, user preferences, patterns of use), according to smoker age group.

Study Locations (1)

Pennsylvania

  • Center for Interdisciplinary Research on Nicotine Addiction - Philadelphia

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-09-05
Est. Completion 2026-07

What the Registry Record Tells You About NCT07214168

The ClinicalTrials.gov registry entry for NCT07214168 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 434-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (77% lower). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Smoking Behaviors appearing as the primary indexed condition, and to 0 interventions.

NCT07214168 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07214168 about?

NCT07214168 is a clinical study titled "Vape Use Among Younger & Older Smokers". The study aims to recruit 100 current cigarette smokers (50 young adults ages 21-34; 50 older adults ages 35-65) who have tried vaping or are currently vaping (dual users). The study will examine the trajectories in tobacco use (cigarettes and/or ENDS), including the nuanced differences in ENDS use ...

What is the current status of trial NCT07214168?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-09-05. Estimated completion is 2026-07.

What conditions does trial NCT07214168 study?

This clinical trial studies the following conditions: Smoking Behaviors, Smoking, Cigarette, Vaping, Vaping Behaviors.

Who is sponsoring clinical trial NCT07214168?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07214168 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Behaviors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.